Marinus Pharma (MRNS) Reports Q2 Loss of $0.46

Marinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.46), versus ($0.37) reported last year.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• UBS Downgrades Lai Yih Footwear Co Ltd (6890:TT) to Neutral